Daniel

Real-World Evidence Data Scientist, Amsterdam UMC
  • Netherlands

About Daniel

I am passionate about pharmacoepidemiology, pharmacovigilance and medical informatics. Currently,  I am working on kidney medication safety at Amsterdam University Medical Centres.

Intro Content

Drug Safety

An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury

Acute Kidney Injury (AKI) is increasingly relevant, with many cases linked to preventable adverse drug reactions. This study compiles data from four sources on 63 drugs with AKI potential, aiming to enhance prescription practices and nephrotoxin stewardship for improved kidney safety.

Topics

Channels contributed to:

Behind the Paper

Online Elsewhere